S100A9 and hypertriglyceridemia: In conclusion, S100A9's ability to normalize hyperketonemia and hypertriglyceridemia in ID is primarily driven by TLR4 signaling in KCs, uncovering a novel mechanism for regulating metabolic dysfunction.